MOHCCN Seminar Series: Princess Margaret Cancer Consortium

Updates from leadership and researchers at the Princess Margaret Cancer Consortium held in Feb. 2024.

<div style="padding:51.15% 0 0 0;position:relative;"><iframe src="https://player.vimeo.com/video/918391712?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479" frameborder="0" allow="autoplay; fullscreen; picture-in-picture; clipboard-write" style="position:absolute;top:0;left:0;width:100%;height:100%;" title="MOHCCN Seminar Series: Princess Margaret Cancer Consortium (Season 2)"></iframe></div><script src="https://player.vimeo.com/api/player.js"></script>
PM2C CONSORTIUM ACTIVITIES UPDATE

Dr. Lillian Siu - Medical Oncologist, Princess Margaret Cancer Centre (PMCC), University Health Network (UHN); MOHCCN consortium lead (PM2C)

Dr. Amber Simpson - Associate Professor, Queen's University; Canada Research Chair in Biomedical Computing and Informatics; MOHCCN Kingston / Queen's University institutional lead

RESEARCH PRESENTATIONS

Identification and clinical implications of circular RNA in cancer

Dr. Hansen He - Senior Scientist, PMCC, UHN; Professor, Department of Medical Biophysics, University of Toronto; MOHCCN cohort lead

View abstract and plain language summary

Shedding light on the surge: Investigating the etiology of young onset colorectal cancer

Dr. Kevin Wang - Medical Oncology Fellow, Eliot Phillipson Clinician-Scientist Training Program, PMCC, UHN

View abstract and plain language summary